A first trimester trisomy 13/trisomy 18 risk algorithm combining fetal nuchal translucency thickness, maternal serum free β‐hCG and PAPP‐A
- 3 September 2002
- journal article
- research article
- Published by Wiley in Prenatal Diagnosis
- Vol. 22 (10) , 877-879
- https://doi.org/10.1002/pd.420
Abstract
This study examines 45 cases of trisomy 13 and 59 cases of trisomy 18 and reports an algorithm to identify pregnancies with a fetus affected by trisomy 13 or 18 by a combination of maternal age fetal nuchal translucency (NT) thickness, and maternal serum free β-hCG and PAPP-A at 11–14 weeks of gestation. In this mixed trisomy group the median MoM NT was increased at 2.819, whilst the median MoMs for free β-hCG and PAPP-A were reduced at 0.375 and 0.201 respectively. We predict that with the use of the combined trisomy 13 and 18 algorithm and a risk cut-off of 1 in 150 will for a 0.3% false positive rate allow 95% of these chromosomal defects to be identified at 11–14 weeks. Such algorithms will enhance existing first trimester screening algorithms for trisomy 21. Copyright © 2002 John Wiley & Sons, Ltd.Keywords
This publication has 14 references indexed in Scilit:
- Second trimester levels of pregnancy associated plasma protein-A in cases of trisomy 18Prenatal Diagnosis, 1999
- Increased nuchal translucency in trisomy 13 fetuses at 10-14 weeks of gestationAmerican Journal of Medical Genetics, 1999
- A screening program for trisomy 21 at 10–14 weeks using fetal nuchal translucency, maternal serum free β‐human chorionic gonadotropin and pregnancy‐associated plasma protein‐AUltrasound in Obstetrics & Gynecology, 1999
- UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10–14 weeks of gestationThe Lancet, 1998
- Letter. Correct estimation of parameters for ultrasound nuchal translucency screeningPrenatal Diagnosis, 1998
- Prenatal diagnosis of trisomy 18 at the 10–14‐week ultrasound scanUltrasound in Obstetrics & Gynecology, 1997
- REFINEMENTS IN MANAGING MATERNAL WEIGHT ADJUSTMENT FOR INTERPRETING PRENATAL SCREENING RESULTSPrenatal Diagnosis, 1996
- Maternal Age and Gestational Age-Specific Risk for Chromosomal DefectsFetal Diagnosis and Therapy, 1995
- Model‐based screening by risk with application to down's syndromeStatistics in Medicine, 1992
- The Mathematical Basis of Multivariate Risk Screening: With Special Reference to Screening for Down's Syndrome Associated PregnancyAnnals of Clinical Biochemistry: International Journal of Laboratory Medicine, 1990